Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Dhanushkodi M"" wg kryterium: Autor


Wyświetlanie 1-4 z 4
Tytuł :
Olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced vomiting in children: An open-label, randomized phase 3 trial.
Autorzy :
Radhakrishnan V; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Pai V; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Rajaraman S; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Mehra N; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Ganesan T; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Dhanushkodi M; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Perumal Kalaiyarasi J; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Rajan AK; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Selvarajan G; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Ranganathan R; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Karunakaran P; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Sagar TG; Department of Medical Oncology (Pediatric Oncology Division) and Biostatistics, Cancer Institute (WIA), Adyar, Chennai, Tamilnadu, India.
Pokaż więcej
Źródło :
Pediatric blood & cancer [Pediatr Blood Cancer] 2020 Sep; Vol. 67 (9), pp. e28532. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Antiemetics/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Metoclopramide/*therapeutic use
Neoplasms/*drug therapy
Olanzapine/*therapeutic use
Vomiting/*drug therapy
Adolescent ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Humans ; Male ; Neoplasms/pathology ; Prognosis ; Vomiting/chemically induced ; Vomiting/pathology
Czasopismo naukowe
Tytuł :
A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin.
Autorzy :
Mehra N; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, 600036, India.
Christopher V; Department of Radiation Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, 600036, India.
Dhanushkodi M; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, 600036, India.
Radhakrishnan V; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, 600036, India.
Ganesan TS; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, 600036, India.
Ganesharajah S; Department of Radiation Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, 600036, India.
Sagar TG; Department of Medical Oncology, Cancer Institute (WIA), Adyar, Chennai, Tamil Nadu, 600036, India.
Ganesan P; Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, 605006, India. .
Pokaż więcej
Źródło :
International journal of clinical pharmacy [Int J Clin Pharm] 2020 Apr; Vol. 42 (2), pp. 662-666. Date of Electronic Publication: 2020 Mar 09.
Typ publikacji :
Journal Article
MeSH Terms :
Antiemetics/*administration & dosage
Antineoplastic Agents/*adverse effects
Cisplatin/*adverse effects
Nausea/*drug therapy
Olanzapine/*administration & dosage
Vomiting/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Drug Administration Schedule ; Female ; Humans ; India/epidemiology ; Middle Aged ; Nausea/chemically induced ; Nausea/epidemiology ; Uterine Cervical Neoplasms/drug therapy ; Uterine Cervical Neoplasms/epidemiology ; Vomiting/chemically induced ; Vomiting/epidemiology ; Young Adult
Czasopismo naukowe
    Wyświetlanie 1-4 z 4

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies